312 related articles for article (PubMed ID: 16973336)
1. Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel.
Nir-Paz R; Block C; Shasha D; Korenman Z; Gorodnitzky Z; Jaffe J; Ron M; Michael-Gayego A; Cohen-Poradosu R; Shapiro M; Moses AE
Int J Antimicrob Agents; 2006 Oct; 28(4):313-9. PubMed ID: 16973336
[TBL] [Abstract][Full Text] [Related]
2. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of emm types 1 and 12 from invasive Streptococcus pyogenes disease in Greece--results of enhanced surveillance.
Stathi A; Papaparaskevas J; Zachariadou L; Pangalis A; Legakis NJ; Tseleni-Kotsovili A; ; Tassios PT
Clin Microbiol Infect; 2008 Aug; 14(8):808-12. PubMed ID: 18727807
[TBL] [Abstract][Full Text] [Related]
4. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
Koh EH; Kim S; Lee NY
Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Streptococcus pyogenes strains isolated from Chinese children with scarlet fever.
Liang Y; Shen X; Huang G; Wang C; Shen Y; Yang Y
Acta Paediatr; 2008 Dec; 97(12):1681-5. PubMed ID: 18691162
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of tetracycline and macrolide resistance and emm characterization of Streptococcus pyogenes isolates in Tunisia.
Hraoui M; Boutiba-Ben Boubaker I; Doloy A; Ben Redjeb S; Bouvet A
Microb Drug Resist; 2011 Sep; 17(3):377-82. PubMed ID: 21612508
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006).
Rubio-López V; Valdezate S; Alvarez D; Villalón P; Medina MJ; Salcedo C; Sáez-Nieto JA
BMC Microbiol; 2012 Sep; 12():215. PubMed ID: 22998619
[TBL] [Abstract][Full Text] [Related]
8. Distribution of emm types among group A streptococcal isolates from Serbia.
Mijac V; Ranin L; Marković M; Heeg C; Reinert RR; Opavski N
Clin Microbiol Infect; 2010 Mar; 16(3):295-8. PubMed ID: 19519840
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological markers of Streptococcus pyogenes strains in Tunisia.
Hraoui M; Boutiba-Ben Boubaker I; Doloy A; Samir E; Ben Redjeb S; Bouvet A
Clin Microbiol Infect; 2011 Jan; 17(1):63-8. PubMed ID: 20132259
[TBL] [Abstract][Full Text] [Related]
10. Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.
Dundar D; Sayan M; Tamer GS
Microb Drug Resist; 2010 Dec; 16(4):279-84. PubMed ID: 20624096
[TBL] [Abstract][Full Text] [Related]
11. [Macrolide resistance phenotypes and genotypes in group G streptococci].
Açikgöz ZC; Göçer S; Almayanlar E
Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007.
Imöhl M; Reinert RR; Ocklenburg C; van der Linden M
FEMS Immunol Med Microbiol; 2010 Apr; 58(3):389-96. PubMed ID: 20146737
[TBL] [Abstract][Full Text] [Related]
13. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
14. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
Ardanuy C; Domenech A; Rolo D; Calatayud L; Tubau F; Ayats J; Martín R; Liñares J
J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
[TBL] [Abstract][Full Text] [Related]
16. Macrolide resistance determinants of group A streptococci in Ankara, Turkey.
Acikgoz ZC; Gocer S; Tuncer S
J Antimicrob Chemother; 2003 Jul; 52(1):110-2. PubMed ID: 12805256
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
18. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
[TBL] [Abstract][Full Text] [Related]
19. Molecular Characteristics of Erythromycin-Resistant Streptococcus pyogenes Strains Isolated from Children Patients in Tunis, Tunisia.
Ksia S; Smaoui H; Hraoui M; Bouafsoun A; Boutiba-Ben Boubaker I; Kechrid A
Microb Drug Resist; 2017 Jul; 23(5):633-639. PubMed ID: 27991848
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
